Key Differences Between These Two Weight Management Options
What Is Difference Between Wegovy And Mounjaro Availability In The UK?
The primary difference between Wegovy and Mounjaro availability lies in supply chain stability and storage flexibility. Wegovy has experienced supply constraints historically, but EverydayMeds maintains reliable stock of all five doses through our established partnership with Novo Nordisk. Our GPhC-registered pharmacy (#9012878) ensures consistent availability without waitlists or delays. Mounjaro, manufactured by Eli Lilly, has had more consistent UK availability since its launch, though both medications now maintain stable supply chains through authorised distributors.
For UK patients, this availability difference matters significantly when planning treatment continuity. Wegovy's improved supply situation means you can confidently start treatment knowing your dose escalation schedule won't be interrupted. Both medications require prescription-only access through clinical assessment, but having both options readily available provides flexibility for prescribers to choose the most appropriate treatment based on individual patient needs rather than supply constraints.
Wegovy Vs Mounjaro Pricing And Value Comparison
Understanding what is difference between Wegovy and Mounjaro pricing helps inform treatment decisions. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Mounjaro follows a different pricing structure reflecting its dual-hormone mechanism and manufacturing costs.
Bundle options provide convenience for both medications, with Wegovy's Intro Duo (0.25mg & 0.5mg) available for £169.99, ensuring your first two months of treatment arrive together. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, eliminating multiple ordering cycles. These bundles focus on supply security and convenience rather than cost savings, ensuring treatment continuity during your weight management journey.
What Is Difference Between Wegovy And Mounjaro Clinical Evidence?
The clinical evidence reveals distinct profiles when examining what is difference between Wegovy and Mounjaro effectiveness. Wegovy's evidence comes primarily from the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, providing additional health benefits beyond weight management.
Mounjaro's evidence stems from the SURMOUNT trials, showing the dual GIP+GLP-1 mechanism may produce different outcomes in clinical settings. However, comparing these trials directly isn't appropriate due to different study designs, patient populations, and endpoints. Both medications have demonstrated significant efficacy as prescription-only medicines when used alongside lifestyle interventions, with individual responses varying between patients.
How Wegovy Works Compared To Mounjaro's Mechanism
The fundamental difference between Wegovy and Mounjaro lies in their hormonal targets and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, which is released after eating to signal fullness and regulate blood sugar. This single-target approach focuses specifically on appetite centres in the brain, reducing food cravings and promoting earlier satiety during meals. The GLP-1 mechanism also slows gastric emptying, helping you feel satisfied for longer periods after eating. Wegovy's once-weekly injection maintains consistent GLP-1 receptor activation, supporting sustainable appetite control throughout your weight management programme.
Wegovy Vs Mounjaro Ordering Process At EverydayMeds
The ordering process for both Wegovy and Mounjaro follows identical clinical pathways at EverydayMeds, ensuring appropriate prescriber oversight regardless of which medication you and your clinician select. Begin with our 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any contraindications. Your responses are reviewed by our qualified prescribers within 3 working days (or 24 hours with express service), who determine suitability and appropriate starting doses. Once approved, your medication ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. This streamlined process applies to both treatments, with identical safety protocols and clinical oversight throughout.
Storage And Practical Differences Between Wegovy And Mounjaro
A significant practical difference between Wegovy and Mounjaro involves storage requirements and travel convenience. Wegovy offers superior storage flexibility, remaining stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability makes it more travel-friendly for holidays or business trips. The FlexTouch pen design used for Wegovy provides intuitive dose delivery with clear dose escalation from 0.25mg through to 2.4mg maintenance, with each pen containing four weekly doses. This practical advantage can influence treatment choice for patients with active lifestyles or frequent travel commitments.
What Is Difference Between Wegovy And Mounjaro For UK Supply Chain Reliability?
Supply chain reliability represents a crucial difference when comparing Wegovy and Mounjaro availability in the UK market. Wegovy experienced significant supply challenges during 2022-2023, leading to treatment interruptions and patient frustration across multiple dose strengths. However, Novo Nordisk has substantially improved manufacturing capacity and distribution networks, with EverydayMeds now maintaining consistent stock levels across all five doses. Our direct relationships with authorised wholesalers and predictive ordering systems prevent stock-outs that previously affected patient care.
Mounjaro has maintained more consistent UK availability since its market introduction, benefiting from Eli Lilly's established supply chains and manufacturing experience. For patients concerned about treatment continuity, both options now offer reliable availability through EverydayMeds, though Wegovy's recovery from previous supply issues demonstrates robust long-term supply planning. This improved reliability means patients can confidently commit to either treatment pathway without supply-related anxiety affecting their weight management journey.
Making Your Decision: Wegovy Or Mounjaro In Stock Now
Understanding what is difference between Wegovy and Mounjaro helps inform your treatment decision, but individual suitability depends on multiple factors including medical history, lifestyle preferences, and clinical response patterns. Both medications are prescription-only medicines requiring proper clinical assessment and ongoing monitoring by qualified healthcare professionals. Your prescriber will consider factors like existing medical conditions, other medications, injection preferences, and storage requirements when recommending the most appropriate option. EverydayMeds stocks both treatments specifically to provide prescriber flexibility and patient choice, ensuring availability doesn't limit clinical decision-making. Use code FIRST40 for new customers or DOSE25 for returning customers when ordering through https://everydaymeds.co.uk/collections/wegovy, with both options available for next-day delivery following clinical approval.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
